Published in Ann N Y Acad Sci on January 01, 1987
Magnetic resonance imaging of glutamate. Nat Med (2012) 3.17
Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging (2009) 2.41
Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn Reson Med (2001) 2.22
Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging (2009) 2.18
Advancements in MR imaging of the prostate: from diagnosis to interventions. Radiographics (2011) 2.17
In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc (2011) 1.91
Quantitative cardiac 31P spectroscopy at 3 Tesla using adiabatic pulses. Magn Reson Med (2009) 1.83
Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring) (2009) 1.70
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. J Neurooncol (2011) 1.67
Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging (2013) 1.54
Coupling between changes in human brain temperature and oxidative metabolism during prolonged visual stimulation. Proc Natl Acad Sci U S A (2000) 1.54
Simultaneous B(0)- and B(1)+-map acquisition for fast localized shim, frequency, and RF power determination in the heart at 3 T. Magn Reson Med (2010) 1.50
Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biol Psychiatry (2001) 1.49
In vivo water state measurements in breast cancer using broadband diffuse optical spectroscopy. Phys Med Biol (2008) 1.45
Neurocognitive Function and Neuroimaging Markers in Virologically Suppressed HIV-positive Patients Randomized to Ritonavir-boosted Protease Inhibitor Monotherapy or Standard Combination ART: A Cross-sectional Substudy From the PIVOT Trial. Clin Infect Dis (2016) 1.44
Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. MAGMA (2006) 1.40
Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol (2009) 1.39
Magnetic resonance Spectroscopy with Linear Algebraic Modeling (SLAM) for higher speed and sensitivity. J Magn Reson (2012) 1.37
ISMRM workshop on fat-water separation: insights, applications and progress in MRI. Magn Reson Med (2012) 1.35
Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia (2000) 1.34
Real-time motion and B0 corrected single voxel spectroscopy using volumetric navigators. Magn Reson Med (2011) 1.34
Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology (2009) 1.34
Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia. Biol Psychiatry (2010) 1.33
Method for high-resolution imaging of creatine in vivo using chemical exchange saturation transfer. Magn Reson Med (2013) 1.31
Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimaging Clin N Am (2010) 1.31
A technique for in vivo mapping of myocardial creatine kinase metabolism. Nat Med (2014) 1.29
Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients. Neurology (2005) 1.26
Methodology of H NMR Spectroscopy of the Human Brain at Very High Magnetic Fields. Appl Magn Reson (2005) 1.25
Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol (2010) 1.25
Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate. J Clin Invest (2013) 1.24
In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. Eur Biophys J (2009) 1.24
Prospective motion correction for single-voxel 1H MR spectroscopy. Magn Reson Med (2010) 1.22
Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Neurology (2003) 1.22
Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T. Eur Radiol (2004) 1.21
Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings. Int J Radiat Oncol Biol Phys (2007) 1.17
Proton magnetic resonance spectroscopy in multiple sclerosis. Neuroimaging Clin N Am (2009) 1.17
In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain. BMC Neurosci (2009) 1.16
Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content. Diabetes (2008) 1.13
Monitoring and correcting spatio-temporal variations of the MR scanner's static magnetic field. MAGMA (2006) 1.13
Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T. Magn Reson Med (2008) 1.13
MR-visible lipids and the tumor microenvironment. NMR Biomed (2011) 1.13
Serial magnetic resonance spectroscopy reveals a direct metabolic effect of cediranib in glioblastoma. Cancer Res (2011) 1.13
A defect in the mitochondrial complex III, but not complex IV, triggers early ROS-dependent damage in defined brain regions. Hum Mol Genet (2012) 1.13
Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications. Pediatr Radiol (2009) 1.11
Spectroscopic imaging with improved gradient modulated constant adiabaticity pulses on high-field clinical scanners. J Magn Reson (2010) 1.11
Simultaneous acquisition of magnetic resonance spectroscopy (MRS) data and positron emission tomography (PET) images with a prototype MR-compatible, small animal PET imager. J Magn Reson (2007) 1.09
A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS. BMC Neurosci (2004) 1.08
Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology (2002) 1.08
Quantitative proton MR techniques for measuring fat. NMR Biomed (2013) 1.08
Dual inversion recovery, ultrashort echo time (DIR UTE) imaging: creating high contrast for short-T(2) species. Magn Reson Med (2010) 1.07
Prospective motion correction for magnetic resonance spectroscopy using single camera Retro-Grate reflector optical tracking. J Magn Reson Imaging (2011) 1.07
Interleaved narrow-band PRESS sequence with adiabatic spatial-spectral refocusing pulses for 1H MRSI at 7T. Magn Reson Med (2008) 1.07
Neurologic 3D MR spectroscopic imaging with low-power adiabatic pulses and fast spiral acquisition. Radiology (2011) 1.06
Accuracy and stability of measuring GABA, glutamate, and glutamine by proton magnetic resonance spectroscopy: a phantom study at 4 Tesla. J Magn Reson (2010) 1.04
Numerical simulations of localized high field 1H MR spectroscopy. J Magn Reson (2008) 1.04
Frontal lobe γ-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition. Biol Psychiatry (2013) 1.03
Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder. Psychiatry Res (2009) 1.03
Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. J Control Release (2010) 1.03
Highly-accelerated quantitative 2D and 3D localized spectroscopy with linear algebraic modeling (SLAM) and sensitivity encoding. J Magn Reson (2013) 1.03
Spectral localization by imaging using multielement receiver coils. Magn Reson Med (2011) 1.02
Fat suppression for 1H MRSI at 7T using spectrally selective adiabatic inversion recovery. Magn Reson Med (2008) 1.01
Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer. Magn Reson Imaging (2007) 1.01
Abnormal N-acetylaspartate in hippocampus and anterior cingulate in posttraumatic stress disorder. Psychiatry Res (2008) 1.01
A hierarchical spectral clustering and nonlinear dimensionality reduction scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS). Med Phys (2009) 1.00
Estrogen receptor and breast MR imaging features: a correlation study. J Magn Reson Imaging (2008) 1.00
Intracellular and extracellular skeletal muscle triglyceride metabolism during alternating intensity exercise in humans. J Physiol (1998) 1.00
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma. Neuro Oncol (2015) 0.99
The basal ganglia: a substrate for fatigue in multiple sclerosis. Neuroradiology (2007) 0.99
Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer. Top Magn Reson Imaging (2008) 0.99
Imaging brain vasculature with BOLD microscopy: MR detection limits determined by in vivo two-photon microscopy. Magn Reson Med (2008) 0.99
Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer. Acad Radiol (2010) 0.98
Disturbed energy metabolism and muscular dystrophy caused by pure creatine deficiency are reversible by creatine intake. J Physiol (2012) 0.98
Glutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex. J Am Acad Child Adolesc Psychiatry (2007) 0.98
Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance. J Hepatol (2013) 0.98
Reproducibility study of whole-brain 1H spectroscopic imaging with automated quantification. Magn Reson Med (2008) 0.97
Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer. MAGMA (2000) 0.97
Evidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy. Sleep (2009) 0.97
MRI and 1H MRS findings in Smith-Lemli-Opitz syndrome. Neuroradiology (2003) 0.96
IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy. Neuropsychopharmacology (2014) 0.96
Neuropsychological function and cerebral metabolites in HIV-infected youth. J Neuroimmune Pharmacol (2012) 0.95
Change in the proton T(1) of fat and water in mixture. Magn Reson Med (2010) 0.94
Adaptation of brain glutamate plus glutamine during abstinence from chronic methamphetamine use. J Neuroimmune Pharmacol (2008) 0.94
Attention, learning, and memory in posttraumatic stress disorder. J Trauma Stress (2004) 0.94
Biochemical correlates of neuropsychiatric illness in maple syrup urine disease. J Clin Invest (2013) 0.93
Distinct patterns of fat metabolism in skeletal muscle of normal-weight, overweight, and obese humans. Am J Physiol Regul Integr Comp Physiol (2008) 0.93
Low-power adiabatic sequences for in vivo localized two-dimensional chemical shift correlated MR spectroscopy. Magn Reson Med (2010) 0.93
Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging. J Neurol Neurosurg Psychiatry (2004) 0.93
Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions. AJR Am J Roentgenol (2012) 0.92
Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS. NMR Biomed (2010) 0.92
In vivo proton MRS to quantify anesthetic effects of pentobarbital on cerebral metabolism and brain activity in rat. Magn Reson Med (2009) 0.92
Real-time dynamic frequency and shim correction for single-voxel magnetic resonance spectroscopy. Magn Reson Med (2012) 0.91
Magnetic resonance spectroscopy imaging of the newborn brain--a technical review. Semin Perinatol (2010) 0.90
Detection of choline signal in human breast lesions with chemical-shift imaging. J Magn Reson Imaging (2008) 0.90
Early Expression of Parkinson's Disease-Related Mitochondrial Abnormalities in PINK1 Knockout Rats. Mol Neurobiol (2014) 0.90
Neonatal brain metabolite concentrations: an in vivo magnetic resonance spectroscopy study with a clinical MR system at 3 Tesla. PLoS One (2013) 0.89
Chemical exchange saturation transfer (CEST) imaging with fast variably-accelerated sensitivity encoding (vSENSE). Magn Reson Med (2016) 0.89
Subcellular in vivo 1H MR spectroscopy of Xenopus laevis oocytes. Biophys J (2005) 0.89
Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging. Schizophr Res (2012) 0.89
Relationship between fractional anisotropy of cerebral white matter and metabolite concentrations measured using (1)H magnetic resonance spectroscopy in healthy adults. Neuroimage (2012) 0.89
B1 and T1 insensitive water and lipid suppression using optimized multiple frequency-selective preparation pulses for whole-brain 1H spectroscopic imaging at 3T. Magn Reson Med (2009) 0.89